Status 2 Upgrade Indication Impacts Post-Transplant Mortality in Patients Bridged with IABP in the New Heart Allocation System.
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
13 Dec 2023
13 Dec 2023
Historique:
received:
30
03
2023
revised:
15
11
2023
accepted:
10
12
2023
medline:
16
12
2023
pubmed:
16
12
2023
entrez:
15
12
2023
Statut:
aheadofprint
Résumé
To evaluate outcomes of patients undergoing heart transplant (HT) using an intra-aortic balloon pump (IABP) under exception status. Adult patients supported with an IABP who underwent HT between 10/18/2018 and 12/31/2020 as documented in UNOS, were included. Patients were stratified according to request for exception status. Kaplan Meier methodology was used to look for differences in survival between groups. A total of 1284 patients were included, 492 (38.3%) were transplanted with an IABP under exception status. Exception status patients had higher BMI, were more likely to be Black, and to have longer waitlist time. Exception status patients received organs from younger donors, had a shorter ischemic time and a higher frequency of sex mismatch. The one-year post transplant survival was 93% for the non-exception and 88% for exception IABP patients (HR 1.85 (1.12-2.86, p =0.006). The most common cause for request of an exception status was inability to meet blood pressure criteria for extension (37% of patients). The most common reason for extension request of exception status was right ventricular dysfunction (24%). IABP patients transplanted under exception status have an increased one-year mortality post transplantation compared to those without exception status.
Identifiants
pubmed: 38101475
pii: S1600-6135(23)00909-7
doi: 10.1016/j.ajt.2023.12.009
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.